Profile
Michael A. Caligiuri is the founder of Cytoimmune Therapeutics, Inc., a company founded in 2019 where he holds the title of Chief Medical Officer.
He currently holds the position of Director-Comprehensive Cancer Center at The Ohio University, Director at The Ohio State University Wexner Medical Center, and Director at Pelotonia.
In the past, he served as Chief Executive Officer at James Cancer Hospital, Chief Executive Officer & Director at Ohio State University Comprehensive Cancer Center, Independent Member-Supervisory Board at Innate Pharma SA, President-Elect at American Association for Cancer Research, and Co-President at City of Hope National Medical Center.
Michael A. Caligiuri active positions
| Companies | Position | Start |
|---|---|---|
The Ohio University
The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Ohio State University Wexner Medical Center
The Ohio State University Wexner Medical Center Medical/Nursing ServicesHealth Services Provides healthcare services | Director/Board Member | - |
Pelotonia
Pelotonia Miscellaneous Commercial ServicesCommercial Services Provides cancer research services for charity | Director/Board Member | - |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Founder | 2019-05-31 |
Former positions of Michael A. Caligiuri
| Companies | Position | End |
|---|---|---|
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | President | 2018-04-17 |
James Cancer Hospital
James Cancer Hospital Hospital/Nursing ManagementHealth Services Operates cancer hospitals | Chief Executive Officer | 2017-11-14 |
City of Hope National Medical Center
City of Hope National Medical Center BiotechnologyHealth Technology Operates biomedical research and treatment center for cancer, diabetes and other life-threatening diseases | President | - |
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Engages in research, education, prevention and treatment of cancer | Chief Executive Officer | - |
| INNATE PHARMA | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
The Ohio University
The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
James Cancer Hospital
James Cancer Hospital Hospital/Nursing ManagementHealth Services Operates cancer hospitals | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
The Ohio State University Wexner Medical Center
The Ohio State University Wexner Medical Center Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Engages in research, education, prevention and treatment of cancer | Commercial Services |
Pelotonia
Pelotonia Miscellaneous Commercial ServicesCommercial Services Provides cancer research services for charity | Commercial Services |
City of Hope National Medical Center
City of Hope National Medical Center BiotechnologyHealth Technology Operates biomedical research and treatment center for cancer, diabetes and other life-threatening diseases | Health Technology |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Health Technology |
- Stock Market
- Insiders
- Michael A. Caligiuri
















